Author： Bridges John F.P.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.28, Iss.3, 2010-03, pp. : 175-184
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Access to resources
Recommend
Legal spotlight on healthcare rationing in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 293, 2000-01 ,pp. :
The NICE Cost-Effectiveness Threshold: What it is and What that Means
PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. :
Reduction of NICE cost-effectiveness threshold recommended
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 532, 2007-01 ,pp. :
A closer look at the NICE cost-effectiveness threshold
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :